Musa Yilmaz

Naveen Pemmaraju Highlighted Musa Yilmaz’s EHA 2025 Presentation on DEC/VEN/QUIZ in FLT3-ITD AML

Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on X:

“EHA 2025 Wonderful job, oral presentation at European Hematology Association by our own Musa Yilmaz, MD Anderson Cancer Center on DEC/VEN/QUIZ combination for patients with FLT3ITD AML.”

Musa Yilmaz

More posts featuring Naveen Pemmaraju on OncoDaily. 

AML cancer EHA 2025 EHA25 European Hematology Association FLT3ITD AML MD Anderson Cancer Center Musa Yilmaz Naveen Pemmaraju OncoDaily Oncology